Clinical Study
Radiographic Parameters in Predicting Outcome of Patients with Hepatocellular Carcinoma Treated with Yttrium-90 Microsphere Radioembolization
Table 2
Characteristics of patients with hepatocellular carcinoma who were treated with selective internal radiotherapy with Yttrium-90 microspheres*.
| | Characteristic | |
| | Age (y) | 63 (50 to 87) | | Sex | | | Men | 18 (79%) | | Women | 5 (21%) | | Race | | | African American | 14 (61%) | | White | 6 (26%) | | Other | 3 (13%) | | Ascites | 5 (24%) | | Extrahepatic metastatic disease | 4 (17%) | | Laboratory values | | | Albumin (g/dL) | 2.7 (2.7 to 4.9) | | Total bilirubin (mg/dL) | 0.8 (0.2 to 2.6) | | -fetoprotein (g/L) | 108 (1.4 to 462400) | | Computed tomography of tumors† | | | Tumor size (cm) | 8.1 (2.3 to 17) | | Attenuation (HU) | 35 (20 to 65.2) | | <50% necrosis | 21 (95%) | | Well-defined margins | 9 (39%) | | Enhancement (heterogeneous) | 21 (95%) | | Central hypervascularity | 12 (52%) | | Hepatopulmonary shunt fraction | 0.056 (0.014 to 0.165) | | Peripheral hypervascularity pattern | 6 (43%) |
|
|
patients. Data reported as median (range, minimum to maximum) or number (%) patients.
†Before selective internal radiotherapy.
|
